BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29518893)

  • 1. Antibacterial and Antifungal Activities of Poloxamer Micelles Containing Ceragenin CSA-131 on Ciliated Tissues.
    Hashemi MM; Holden BS; Taylor MF; Wilson J; Coburn J; Hilton B; Nance T; Gubler S; Genberg C; Deng S; Savage PB
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29518893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis.
    Oyardi Ö; Savage PB; Erturan Z; Bozkurt-Guzel C
    J Antimicrob Chemother; 2021 Jan; 76(2):443-450. PubMed ID: 33094334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
    Hashemi MM; Rovig J; Holden BS; Taylor MF; Weber S; Wilson J; Hilton B; Zaugg AL; Ellis SW; Yost CD; Finnegan PM; Kistler CK; Berkow EL; Deng S; Lockhart SR; Peterson M; Savage PB
    J Antimicrob Chemother; 2018 Jun; 73(6):1537-1545. PubMed ID: 29635279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of ceragenins for prevention of bacterial colonization of hydrogel contact lenses.
    Gu X; Jennings JD; Snarr J; Chaudhary V; Pollard JE; Savage PB
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6217-23. PubMed ID: 23970466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida species.
    Bozkurt-Guzel C; Hacioglu M; Savage PB
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):324-330. PubMed ID: 29680320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.
    Leszczyńska K; Namiot A; Cruz K; Byfield FJ; Won E; Mendez G; Sokołowski W; Savage PB; Bucki R; Janmey PA
    J Appl Microbiol; 2011 Jan; 110(1):229-38. PubMed ID: 20961363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.
    Niemirowicz K; Surel U; Wilczewska AZ; Mystkowska J; Piktel E; Gu X; Namiot Z; Kułakowska A; Savage PB; Bucki R
    J Nanobiotechnology; 2015 May; 13():32. PubMed ID: 25929281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial peptide-inspired NH125 analogues: bacterial and fungal biofilm-eradicating agents and rapid killers of MRSA persisters.
    Basak A; Abouelhassan Y; Zuo R; Yousaf H; Ding Y; Huigens RW
    Org Biomol Chem; 2017 Jul; 15(26):5503-5512. PubMed ID: 28534905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
    Zacchino SA; Butassi E; Cordisco E; Svetaz LA
    Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.
    Bucki R; Niemirowicz K; Wnorowska U; Byfield FJ; Piktel E; Wątek M; Janmey PA; Savage PB
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6274-82. PubMed ID: 26248361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic.
    Hashemi MM; Rovig J; Bateman J; Holden BS; Modelzelewski T; Gueorguieva I; von Dyck M; Bracken R; Genberg C; Deng S; Savage PB
    J Antimicrob Chemother; 2018 Jan; 73(1):143-150. PubMed ID: 29029265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum.
    Bucki R; Sostarecz AG; Byfield FJ; Savage PB; Janmey PA
    J Antimicrob Chemother; 2007 Sep; 60(3):535-45. PubMed ID: 17584802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting pathogenic fungi, bacteria and fungal-bacterial biofilms by newly synthesized quaternary ammonium derivative of pyridoxine and terbinafine with dual action profile.
    Garipov MR; Sabirova AE; Pavelyev RS; Shtyrlin NV; Lisovskaya SA; Bondar OV; Laikov AV; Romanova JG; Bogachev MI; Kayumov AR; Shtyrlin YG
    Bioorg Chem; 2020 Nov; 104():104306. PubMed ID: 33011535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganisms.
    Bozkurt Guzel C; Oyardi O; B Savage P
    J Chemother; 2018; 30(6-8):332-337. PubMed ID: 30663553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial and biofilm inhibiting diketopiperazines.
    de Carvalho MP; Abraham WR
    Curr Med Chem; 2012; 19(21):3564-77. PubMed ID: 22709011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13.
    Niemirowicz K; Durnaś B; Tokajuk G; Piktel E; Michalak G; Gu X; Kułakowska A; Savage PB; Bucki R
    Sci Rep; 2017 Jul; 7(1):4610. PubMed ID: 28676673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiofilm activities of ceragenins and antimicrobial peptides against fungal-bacterial mono and multispecies biofilms.
    Hacioglu M; Oyardi O; Bozkurt-Guzel C; Savage PB
    J Antibiot (Tokyo); 2020 Jul; 73(7):455-462. PubMed ID: 32203127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteria.
    Isogai E; Isogai H; Takahashi K; Okumura K; Savage PB
    Oral Microbiol Immunol; 2009 Apr; 24(2):170-2. PubMed ID: 19239645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Multidrug-Resistant Bacteria, Isolated from Water and Plants in Nigeria, to Ceragenins.
    Hashemi MM; Mmuoegbulam AO; Holden BS; Coburn J; Wilson J; Taylor MF; Reiley J; Baradaran D; Stenquist T; Deng S; Savage PB
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30563216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection.
    Wnorowska U; Piktel E; Deptuła P; Wollny T; Król G; Głuszek K; Durnaś B; Pogoda K; Savage PB; Bucki R
    Sci Rep; 2022 Nov; 12(1):19164. PubMed ID: 36357517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.